BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yeo IJ, Lee CK, Han SB, Yun J, Hong JT. Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacol Ther 2019;203:107394. [PMID: 31356910 DOI: 10.1016/j.pharmthera.2019.107394] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Long QH, Wu YG, He LL, Ding L, Tan AH, Shi HY, Wang P. Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the Aβ deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice. Chin Med 2021;16:14. [PMID: 33478552 DOI: 10.1186/s13020-021-00425-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mhaidly R, Mechta-grigoriou F. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies. Seminars in Immunology 2020;48:101417. [DOI: 10.1016/j.smim.2020.101417] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
3 Yu JE, Yeo IJ, Son DJ, Yun J, Han SB, Hong JT. Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization. Mol Oncol 2021. [PMID: 34861103 DOI: 10.1002/1878-0261.13152] [Reference Citation Analysis]
4 Jeon SH, Lee YS, Yeo IJ, Lee HP, Yoon J, Son DJ, Han SB, Hong JT. Inhibition of Chitinase-3-like-1 by K284-6111 Reduces Atopic Skin Inflammation via Repressing Lactoferrin. Immune Netw 2021;21:e22. [PMID: 34277112 DOI: 10.4110/in.2021.21.e22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Liu W, Yang YJ, An Q. LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis. Cancer Manag Res 2020;12:463-73. [PMID: 32021459 DOI: 10.2147/CMAR.S229083] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
6 Peltonen R, Gramkow MH, Dehlendorff C, Osterlund PJ, Johansen JS, Isoniemi H. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases. PLoS One 2020;15:e0236569. [PMID: 32756596 DOI: 10.1371/journal.pone.0236569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Hermunen K, Soveri LM, Boisen MK, Mustonen HK, Dehlendorff C, Haglund CH, Johansen JS, Osterlund P. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer. Acta Oncol 2020;59:1416-23. [PMID: 32790589 DOI: 10.1080/0284186X.2020.1800086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ham HJ, Lee YS, Yun J, Son DJ, Lee HP, Han SB, Hong JT. K284-6111 alleviates memory impairment and neuroinflammation in Tg2576 mice by inhibition of Chitinase-3-like 1 regulating ERK-dependent PTX3 pathway. J Neuroinflammation 2020;17:350. [PMID: 33222690 DOI: 10.1186/s12974-020-02022-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Yang PS, Yu MH, Hou YC, Chang CP, Lin SC, Kuo IY, Su PC, Cheng HC, Su WC, Shan YS, Wang YC. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics 2022;12:340-61. [PMID: 34987649 DOI: 10.7150/thno.65522] [Reference Citation Analysis]
10 Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL. Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. J Pathol 2020;252:114-24. [PMID: 32613636 DOI: 10.1002/path.5503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Sørensen MS, Colding-Rasmussen T, Horstmann PF, Hindsø K, Dehlendorff C, Johansen JS, Petersen MM. Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers (Basel) 2021;13:2833. [PMID: 34200156 DOI: 10.3390/cancers13112833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Angiulli F, Conti E, Zoia CP, Da Re F, Appollonio I, Ferrarese C, Tremolizzo L. Blood-Based Biomarkers of Neuroinflammation in Alzheimer's Disease: A Central Role for Periphery? Diagnostics (Basel) 2021;11:1525. [PMID: 34573867 DOI: 10.3390/diagnostics11091525] [Reference Citation Analysis]
13 Chen W, Jiang X, Yang Q. Glycoside hydrolase family 18 chitinases: The known and the unknown. Biotechnology Advances 2020;43:107553. [DOI: 10.1016/j.biotechadv.2020.107553] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
14 Witkowski JM, Bryl E, Fulop T. Should we Try to Alleviate Immunosenescence and Inflammaging - Why, How and to What Extent? Curr Pharm Des 2019;25:4154-62. [PMID: 31713479 DOI: 10.2174/1381612825666191111153016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Li L, Wei K, Ding Y, Ahati P, Xu H, Fang H, Wang H. M2a Macrophage-Secreted CHI3L1 Promotes Extracellular Matrix Metabolic Imbalances via Activation of IL-13Rα2/MAPK Pathway in Rat Intervertebral Disc Degeneration. Front Immunol 2021;12:666361. [PMID: 34168643 DOI: 10.3389/fimmu.2021.666361] [Reference Citation Analysis]
16 Wilczyńska K, Waszkiewicz N. Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review. J Clin Med 2020;9:E3452. [PMID: 33121040 DOI: 10.3390/jcm9113452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kjaergaard AD, Chen IM, Johansen AZ, Nordestgaard BG, Bojesen SE, Johansen JS. Inflammatory Biomarker Score Identifies Patients with Six-Fold Increased Risk of One-Year Mortality after Pancreatic Cancer. Cancers (Basel) 2021;13:4599. [PMID: 34572824 DOI: 10.3390/cancers13184599] [Reference Citation Analysis]
18 Xavier CPR, Castro I, Caires HR, Ferreira D, Cavadas B, Pereira L, Santos LL, Oliveira MJ, Vasconcelos MH. Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine. Cancer Lett 2021;501:210-23. [PMID: 33212158 DOI: 10.1016/j.canlet.2020.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
19 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Pinteac R, Montalban X, Comabella M. Chitinases and chitinase-like proteins as biomarkers in neurologic disorders. Neurol Neuroimmunol Neuroinflamm 2021;8:e921. [PMID: 33293459 DOI: 10.1212/NXI.0000000000000921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Comabella M, Deutschmann C, Midaglia L, Schierack P, Martínez J, Roggenbuck D, Montalban X. Chitinase 3-like 1 is not a target antigen in patients with multiple sclerosis. Mult Scler 2021;27:1455-7. [PMID: 33327838 DOI: 10.1177/1352458520980141] [Reference Citation Analysis]
22 Rasmussen LS, Yilmaz MK, Falkmer UG, Poulsen LØ, Bøgsted M, Christensen HS, Bojesen SE, Jensen BV, Chen IM, Johansen AZ, Hansen CP, Hasselby JP, Holländer N, Nielsen SE, Andersen F, Bjerregaard JK, Pfeiffer P, Johansen JS. Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer. Eur J Cancer 2021;144:72-80. [PMID: 33341448 DOI: 10.1016/j.ejca.2020.10.038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
23 Johansen AZ, Carretta M, Thorseth M, Khan S, Fjæstad KY, Brøchner CB, Linder H, Ankjærgaard C, Donia M, Chen I, Nielsen DL, Behrens CP, Madsen DH. Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer. Pharmaceutics 2022;14:1046. [DOI: 10.3390/pharmaceutics14051046] [Reference Citation Analysis]
24 Holst CB, Christensen IJ, Skjøth-Rasmussen J, Hamerlik P, Poulsen HS, Johansen JS. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40. Front Oncol 2020;10:478. [PMID: 32363159 DOI: 10.3389/fonc.2020.00478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Shi G, Chen W, Gong P, Wang M, Zhou J, Wang X, Guo M, Lu J, Li Y, Feng H, Fu X, Zhou R, Xue S. The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke. J Inflamm Res 2021;14:4361-9. [PMID: 34511972 DOI: 10.2147/JIR.S329612] [Reference Citation Analysis]
26 Bielawski K, Rhone P, Bulsa M, Ruszkowska-Ciastek B. Pre-Operative Combination of Normal BMI with Elevated YKL-40 and Leptin but Lower Adiponectin Level Is Linked to a Higher Risk of Breast Cancer Relapse: A Report of Four-Year Follow-Up Study. J Clin Med 2020;9:E1742. [PMID: 32512860 DOI: 10.3390/jcm9061742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Wilczyńska K, Maciejczyk M, Zalewska A, Waszkiewicz N. Serum Amyloid Biomarkers, Tau Protein and YKL-40 Utility in Detection, Differential Diagnosing, and Monitoring of Dementia. Front Psychiatry 2021;12:725511. [PMID: 34589009 DOI: 10.3389/fpsyt.2021.725511] [Reference Citation Analysis]
28 Kang K, Kim K, Lee SR, Kim Y, Lee JE, Lee YS, Lim JH, Lim CS, Kim YJ, Baek SI, Song DH, Hong JT, Kim DY. Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries. Int J Mol Sci 2020;21:E6354. [PMID: 32883029 DOI: 10.3390/ijms21176354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lehtomäki K, Mustonen H, Kellokumpu-Lehtinen PL, Joensuu H, Hermunen K, Soveri LM, Boisen MK, Dehlendorff C, Johansen JS, Haglund C, Osterlund P. Lead Time and Prognostic Role of Serum CEA, CA19-9, IL-6, CRP, and YKL-40 after Adjuvant Chemotherapy in Colorectal Cancer. Cancers (Basel) 2021;13:3892. [PMID: 34359796 DOI: 10.3390/cancers13153892] [Reference Citation Analysis]
30 Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, Gold R, Lukas C, Haghikia A. Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS. Neurol Neuroimmunol Neuroinflamm 2021;8:e906. [PMID: 33172960 DOI: 10.1212/NXI.0000000000000906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Roslind A, Palle C, Johansen JS, Christensen IJ, Nielsen HJ, Mosgaard BJ. Prognostic utility of serum YKL-40 in patients with cervical cancer. Scand J Clin Lab Invest 2020;80:687-93. [PMID: 33186077 DOI: 10.1080/00365513.2020.1846209] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Komabashiri N, Suehiro F, Ishii M, Nishimura M. Efficacy of chitinase-3-like protein 1 as an in vivo bone formation predictable marker of maxillary/mandibular bone marrow stromal cells. Regen Ther 2021;18:38-50. [PMID: 33869686 DOI: 10.1016/j.reth.2021.03.004] [Reference Citation Analysis]